Targeting of bladder cancer with monoclonal antibody NCRC48-a possible approach for intravesical therapy-Reference-Cited by-同舟云学术

Targeting of bladder cancer with monoclonal antibody NCRC48-a possible approach for intravesical therapy

Published:1995-07 Issue:1 Volume:76 Page:81-86
ISSN:0007-1331
Container-title:British Journal of Urology
language:en
Short-container-title:

Author:

KUNKLER R.B.,BISHOP M.C.,GREEN D.J.,PIMM M.V.,PRICE M.R.,FRIER M.

Publisher

Wiley

Subject

Urology,Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.1995.tb07837.x/fullpdf

Reference13 articles.

1. Long-term results of intravesical therapy for superficial bladder cancer;Lamm;Urol Clin North Am,1993

2. Bacillus Calmette Guerin therapy alters the progression of superficial bladder cancer;Herr;J Clin Oncol,1988

3. Immuno-histochemical and immunocytochemical study of bladder carcinomas using the epithelium specific, tumour associated monoclonal antibodies HMFG1 and AUA1;Anagnostaki;Br J Cancer,1990

4. HMFG2 as a prognostic indicator in superficial bladder cancer;Conn;J Clin Pathol,1991

5. Mucin expression by transitional cell carcinomas of the bladder;Walsh;Br J Urol,1994

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MUC1-Targeted Radiopharmaceuticals in Cancer Imaging and Therapy;Molecular Pharmaceutics;2021-04-06

2. Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy;Molecules;2018-05-31

3. Targeted Immunotherapy Designed to Treat MUC1-Expressing Solid Tumour;Current Topics in Microbiology and Immunology;2015

4. MUC1 as a therapeutic target in cancer;Mucins and Cancer;2013-12

5. Design of ligands for the purification of anti-MUC1 antibodies by peptide epitope affinity chromatography;The Journal of Peptide Research;2009-01-12